Have a personal or library account? Click to login
Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects Cover

Antioxidative Effects of Rosuvastatin in Low-to-Moderate Cardiovascular Risk Subjects

Open Access
|Apr 2022

Authors

Ana Vavlukis

ana.vavlukis@gmail.com

Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Marija Vavlukis

marija.vavlukis@gmail.com

Ss. Cyril and Methodius University in Skopje, Faculty of Medicine

Kristina Mladenovska

krml@ff.ukim.edu.mk

Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy

Aleksandar Dimovski

adimovski@ff.ukim.edu.mk

Ss. Cyril and Methodius University in Skopje, Faculty of Pharmacy

Natàlia Muñoz-García

nmunoz@santpau.cat

Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Victoria de Santisteban Villaplana

vsantisteban@santpau.cat

Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Teresa Padro

tpadro@santpau.cat

Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

Lina Badimon

lbadimon@santpau.cat

Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
DOI: https://doi.org/10.2478/prilozi-2022-0007 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Language: English
Page range: 65 - 75
Published on: Apr 22, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2022 Ana Vavlukis, Marija Vavlukis, Kristina Mladenovska, Aleksandar Dimovski, Natàlia Muñoz-García, Victoria de Santisteban Villaplana, Teresa Padro, Lina Badimon, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.